Home › Lung Diseases › North Carolina › Winston-Salem
Lung Diseases clinical trials in Winston-Salem, NC
5 studies for Lung Diseases are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Winston-Salem
American Lung Association (ALA) Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- Wake Forest School of Medicine, Winston-Salem
Deep Functional Phenotyping of the ALA Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- Wake Forest School of Medicine, Winston-Salem
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Southeastern Research Center, Winston-Salem
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingPhase 3
- Wake Forest Baptist Health, Winston-Salem
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Columbus, OH10 studies
- Nashville, TN10 studies
- Los Angeles, CA10 studies
- Dallas, TX10 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Ann Arbor, MI10 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Breast Cancer14 studies
- Multiple Myeloma14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- Ovarian Cancer10 studies
- COPD9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Lung Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.